TD Cowen analyst Andrew Kligerman lowered the firm’s price target on MetLife (MET) to $99 from $102 and keeps a Buy rating on the shares. The firm updated its model following Q4 results.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MET:
- MetLife price target raised to $109 from $101 at Morgan Stanley
- MetLife Announces Leadership Changes and Board Expansion
- MetLife price target raised to $97 from $92 at Wells Fargo
- MetLife price target lowered to $98 from $100 at Keefe Bruyette
- MetLife price target lowered to $95 from $96 at Barclays